Cargando…
Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
Neuroinflammation is one disease hallmark on the road to neurodegeneration in primary tauopathies. Thus, immunomodulation might be a suitable treatment strategy to delay or even prevent the occurrence of symptoms and thus relieve the burden for patients and caregivers. In recent years, the peroxisom...
Autores principales: | Kunze, Lea Helena, Ruch, François, Biechele, Gloria, Eckenweber, Florian, Wind-Mark, Karin, Dinkel, Lina, Feyen, Paul, Bartenstein, Peter, Ziegler, Sibylle, Paeger, Lars, Tahirovic, Sabina, Herms, Jochen, Brendel, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298936/ https://www.ncbi.nlm.nih.gov/pubmed/37373253 http://dx.doi.org/10.3390/ijms241210106 |
Ejemplares similares
-
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020) -
Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
por: Biechele, Gloria, et al.
Publicado: (2020) -
Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
por: Biechele, Gloria, et al.
Publicado: (2022) -
Depletion and activation of microglia impact metabolic connectivity of the mouse brain
por: Gnörich, Johannes, et al.
Publicado: (2023) -
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [(18)F]UCB-H PET imaging
por: Vogler, Letizia, et al.
Publicado: (2023)